Literature DB >> 12464112

Design, expression, and characterization of a synthetic human cannabinoid receptor and cannabinoid receptor/ G-protein fusion protein.

D L Farrens1, T D Dunham, J F Fay, I C Dews, J Caldwell, B Nauert.   

Abstract

We report here the synthesis and characterization of two gene constructs designed to facilitate structure/function studies of the human neuronal cannabinoid receptor, CB1. The first gene, which we call shCB1, is a synthetic gene containing unique restriction sites spaced roughly 50-100 bases apart to facilitate rapid mutagenesis and cloning. A nine amino acid epitope tag (from the rhodopsin C-terminus) is also present in the shCB1 C-terminal tail to enable detection and purification using the monoclonal antibody 1D4. We find that that the shCB1 gene can be transiently expressed in COS cells with yield of approximately 10-15 micro g receptor per 15 cm plate and is wild type like in its ability to bind cannabinoid ligands. Our confocal microscopy studies indicate shCB1 targets to the membrane of HEK293 cells and is internalized in response to agonist. To facilitate functional studies, we also made a chimera in which the C-terminus of shCB1 was fused with the N-terminus of a G-protein alpha subunit, Galphai. The shCB1/Galphai chimera shows agonist stimulated GTPgammaS binding, and thus provides a simplified way to measure agonist induced CB1 activation. Taken together, the shCB1 and shCB1/Galphai gene constructs provide useful tools for biochemical and biophysical examinations of CB1 structure, activation and attenuation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464112     DOI: 10.1034/j.1399-3011.2002.21066.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  7 in total

1.  The synthesis and high-level expression of a beta2-adrenergic receptor gene in a tetracycline-inducible stable mammalian cell line.

Authors:  Prashen Chelikani; Philip J Reeves; Uttam L Rajbhandary; H Gobind Khorana
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

2.  A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569.

Authors:  Jonathan F Fay; David L Farrens
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

3.  β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition.

Authors:  Adrienne L Orr; Jesse E Hanson; Dong Li; Adam Klotz; Sarah Wright; Dale Schenk; Peter Seubert; Daniel V Madison
Journal:  Neuron       Date:  2014-06-18       Impact factor: 17.173

4.  Mass spectrometry-based GPCR proteomics: comprehensive characterization of the human cannabinoid 1 receptor.

Authors:  Nikolai Zvonok; Wei Xu; John Williams; David R Janero; Srinivasan C Krishnan; Alexandros Makriyannis
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

5.  Expression, surface immobilization, and characterization of functional recombinant cannabinoid receptor CB2.

Authors:  Silvia C Locatelli-Hoops; Inna Gorshkova; Klaus Gawrisch; Alexei A Yeliseev
Journal:  Biochim Biophys Acta       Date:  2013-06-15

6.  Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo.

Authors:  Elisheva Smith; Todd E Meyerrose; Thomas Kohler; Malka Namdar-Attar; Natti Bab; Olga Lahat; Tommy Noh; Jingjing Li; Mazen W Karaman; Joseph G Hacia; Ting T Chen; Jan A Nolta; Ralph Müller; Itai Bab; Baruch Frenkel
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

7.  Study of a synthetic human olfactory receptor 17-4: expression and purification from an inducible mammalian cell line.

Authors:  Brian L Cook; Karin E Ernberg; Hyeyoun Chung; Shuguang Zhang
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.